Passer au contenu principal
Centre intégré universitaire de santé
et de services sociaux de l'Est-de-l'Île-de-Montréal

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal

Jean St-Louis, M.D.

Jean St-Louis

Hémato-oncologue, Professeur agrégé de clinique

L'équipe de l’IHOT

Médecin

Contact

Tél. : 514 252-3404

L’expertise et les champs d’intérêt du Dr Jean St-Louis se situent dans les domaines de l’hémophilie et des inhibiteurs de la coagulation. Il a notamment été président de l’Association des directeurs de clinique d’hémophilie du Canada.

 

  • Intervenant principal du Centre de référence québécois pour le traitement des sujets avec inhibiteurs de la coagulation à HMR
  • Codirecteur du Centre d’hémostase du CHU Sainte-Justine
  • Entrée en poste à l’Hôpital Maisonneuve-Rosemont : 2002

 

Formation :

  • Fellowship en hématologie-oncologie : Memorial Sloan-Kettering Cancer Center, New York (États-Unis), 1987-1989
  • Résidences en médecine interne et hématologie : Université de Montréal (Canada), 1983-1987
  • Doctorat en médecine : Université de Montréal (Canada), 1978-1983

Découvrez ses publications

  • Clinical Outcomes of Total Knee Arthroplasty in Patients Who Have Hemophilic Arthropathy: A Prospective Study

    Gautier Beckers, Vincent Massé, Janie Barry , Jean St-Louis , Marc Isler, Pascal-André Vendittoli, Mina Wahba Morcos
    DOI 10.1016/j.arth.2024.07.020 PMID 39025278
    Consulter

  • Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitors

    Evemie Dubé, Clémence Merlen, Arnaud Bonnefoy, Josie Pilon, Nichan Zourikian, Julie Gauthier , Jean St-Louis , Georges-Étienne Rivard
    DOI 10.1111/hae.14685 PMID 36315386
    Consulter

  • The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study

    Jean St-Louis , Audrey Abad, Sharon Funk, Merlyn Tilak, Stephen Classey, Nichan Zourikian, Paul McLaughlin, Sébastien Lobet, Grace Hernandez, Stacie Akins, Anna J Wells, Marilyn Manco-Johnson, Judy John, Steve Austin, Pratima Chowdhary , Cedric Herman, Diane Nugent, Nihal Bakeer, Sarah Mangles, Pamela Hilliard, Victor S Blanchette, Brian M Feldman
    DOI 10.1002/rth2.12690 PMID 35356667
    Consulter

  • Bilateral Pseudoarthrodesis: A Case Report of Complex Bilateral Total Knee Replacement for a Severe Hemophilia A Patient with Inhibitors

    Hussein Assi, Vincent Massé, Hugo Saint-Yves, Janie Barry , Jean St-Louis , Marc Isler
    DOI 10.2106/JBJS.CC.21.00485 PMID 35239593
    Consulter

  • Evaluation of anti-factor VIII antibodies in haemophilia A subjects switching products following a provincial tender

    Evemie Dubé, Clémence Merlen, Arnaud Bonnefoy, Julie Gauthier, Jean-François Castilloux, Janie Charlebois, Stéphanie Cloutier, Christine Demers, Christine A Sabapathy , Jean St-Louis , Catherine Vézina, Margaret Warner, Georges-Étienne Rivard
    DOI 10.1111/hae.14434 PMID 34766421
    Consulter

  • Multidisciplinary Team Care of Patients with Hemophilic Arthropathy: A Qualitative Assessment of Contemporary Practice in the UK and Canada : Canada/UK: MDT Practices for Hemophilia

    Jean St-Louis , Pratima Chowdary, Gerry Dolan, Dawn Goodyear, Karen Strike, Debra Pollard, Jerry Teitel
    DOI 10.1177/10760296211070002 PMID 35060765
    Consulter

  • Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors

    Arnaud Bonnefoy, Clémence Merlen, Evemie Dubé, Hadrien Claus-Desbonnet, Georges-Etienne Rivard , Jean St-Louis
    DOI 10.1111/jth.15515 PMID 34455699
    Consulter

  • A full molecular picture of F8 intron 1 inversion created with optical genome mapping

    Somayyeh Fahiminiya, Georges-Etienne Rivard, Patrick Scott, Alexandre Montpetit, François Bacot , Jean St-Louis , Grant A Mitchell, William D Foulkes, Jean-Francois Soucy, Julie Gauthier
    DOI 10.1111/hae.14375 PMID 34232555
    Consulter

  • A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)

    Evemie Dubé 1, Clémence Merlen 1, Arnaud Bonnefoy 1, Julie Gauthier 2 3, Jean-François Castilloux 4, Stéphanie Cloutier 5, Christine Demers 5, Christine A Sabapathy , Jean St-Louis , Catherine Vézina, Margaret Warner, Georges-Étienne Rivard
    DOI 10.1111/hae.14273 PMID 33555068
    Consulter

  • Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS

    Isolde A.R. Kuijlaars, Janjaap van der Net, Brian M. Feldman, Magnus Aspdahl, Melanie Bladen, Wypke de Boer, Rubén Cuesta-Barriuso, Ruth E.D. Matlary, Sharon M. Funk, Pamela Hilliard, Judy A. John, Christine L. Kempton, Piet de Kleijn , Marilyn Manco-Johnson, Pia Petrini, Pradeep Poonnoose , Jean St-Louis , Sylvia Thomas, Merel A. Timmer, Sonata Saulyte Trakymiene, Leo van Vlimmeren, Kathelijn Fischer
    DOI 10.1111/hae.14180 PMID 33058441
    Consulter

  • Relapse pattern and long-term outcomes in subjects with acquired haemophilia A

    Terry Mizrahi, Karine Doyon, Evemie Dubé, Arnaud Bonnefoy, Margaret Warner, Stéphanie Cloutier, Christine Demers, Jean-François Castilloux, Georges-Etienne Rivard , Jean St-Louis
    DOI 10.1111/hae.13685 PMID 30694571
    Consulter

  • Effect of ABO blood group on haemostatic parameters in severe haemophilia A patients performing acute moderate-intensity exercise

    Clémence Merlen, Nichan Zourikian, Arnaud Bonnefoy, Evemie Dubé, Catherine Thibeault , Jean St-Louis , Georges-Etienne Rivard
    DOI 10.1097/MBC.0000000000000762 PMID 30036280
    Consulter

  • Management of acquired von Willebrand syndrome

    Janie Charlebois, Georges-Étienne Rivard , Jean St-Louis
    DOI 10.1016/j.transci.2018.10.012 PMID 30401518
    Consulter

  • Management of acquired hemophilia A: Review of current evidence

    Janie Charlebois, Georges-Étienne Rivard , Jean St-Louis
    DOI 10.1016/j.transci.2018.10.011 PMID 30396835
    Consulter

  • A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIII

    E. Dubé, A. Bonnefoy, C. Merlen, J.-F. Castilloux, S. Cloutier, C. Demers, C. A. Sabapathy , Jean St-Louis , C. Vezina, M. Warner, G.-É. Rivard
    DOI 10.1111/hae.13410 PMID 29388742
    Consulter

  • Adherence to treatment regimen and bleeding rates in a prospective cohort of youth and young adults on low-dose daily prophylaxis for severe hemophilia A

    Terry Mizrahi , Jean St-Louis , Nancy L Young, Francine Ménard, Nichan Zourikian, Evemie Dubé, Georges E Rivard
    DOI 10.1186/s12878-016-0067-3 PMID 27833753
    Consulter

  • Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A

    V Crivianu-Gaita, G E Rivard, M Carcao, J Teitel , Jean St-Louis , V Blanchette, E Pullenayegum, A Abad, B M Feldman
    DOI 10.1111/hae.13058 PMID 27481574
    Consulter

  • Generic and disease-specific quality of life among youth and young men with Hemophilia in Canada

    Jean St-Louis , D. J. Urajnik, F. Ménard, S. Cloutier, R. J. Klaassen, B. Ritchie, G. E. Rivard, M. Warner, V. Blanchette, N. L. Young
    DOI 10.1186/s12878-016-0052-x PMID 27158500
    Consulter

  • Effects of moderate-intensity physical exercise on pharmacokinetics of factor VIII and von Willebrand factor in young adults with severe haemophilia A: a pilot study

    N Zourikian, C Merlen, A Bonnefoy , Jean St-Louis
    DOI 10.1111/hae.12869 PMID 26988074
    Consulter

  • Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A

    R Kruse-Jarres , Jean St-Louis , A. Greist, A. Shapiro, H. Smith, P. Chowdary, A. Drebes, E. Gomperts, C. Bourgeois, M. Mo, A. Novack, H. Farin, B. Ewenstein
    DOI 10.1111/hae.12627 PMID 25623166
    Consulter

  • Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions

    Shannon C Jackson, Ming Yang, Leonard Minuk, Michelle Sholzberg , Jean St-Louis , Alfonso Iorio, Robert Card, Man-Chiu Poon
    DOI 10.1186/s12878-015-0022-8 PMID 25692030
    Consulter

  • Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures

    Maissaa Janbain, Diane J Nugent, Jerry S Powell , Jean St-Louis , Virginia B Frame, Cindy A Leissinger
    DOI 10.1111/trf.12784 PMID 25070582
    Consulter

  • First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System

    A N Traore, A K C Chan, K E Webert, N Heddle, B Ritchie , Jean St-Louis , J Teitel, D Lillicrap, A Iorio, I Walker
    DOI 10.1111/hae.12477 PMID 24948405
    Consulter

  • Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B

    S C Jackson, M Yang, L Minuk , Jean St-Louis , M Sholzberg, R Card, A Iorio, M C Poon
    DOI 10.1111/hae.12391 PMID 24589126
    Consulter